WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Zhijie Xu
PeerJ Author & Reviewer
3,455 Points

Contributions by role

Author 635
Reviewer 15
Editor 2,805

Contributions by subject area

Bioinformatics
Oncology
Pharmacology
Respiratory Medicine
Molecular Biology
Biochemistry
Epidemiology
Otorhinolaryngology
Histology
Medical Genetics
Gastroenterology and Hepatology
Cell Biology
Women's Health
Genomics
Metabolic Sciences
Toxicology
Cardiology
Cognitive Disorders
Internal Medicine
Neurology
Hematology
Biotechnology
Drugs and Devices
Radiology and Medical Imaging
Immunology
Public Health
Computational Biology
Surgery and Surgical Specialties
Emergency and Critical Care
Infectious Diseases
Pathology
Pediatrics
Virology
HIV
Data Mining and Machine Learning
Orthopedics
Urology
Nephrology
Rheumatology

Zhijie Xu

PeerJ Author & Reviewer

Summary

Prof. Zhijie Xu is an Associate Professor at Xiangya Hospital, Central South University, Hunan, China. He is also a Visiting Researcher at the Mayo Clinic in Minnesota, USA.

Prof. Xu accomplished his Medical Degree (2006-2011) at Xiangya School of Medicine, Central South University, and then received research training and was awarded his Doctoral Degree (2011-2016) at the Cancer Research Institute, Central South University.

Prof. Xu's specialization is Pathology and Pathophysiology in Oncology. His research mainly focuses on the cancer pathogenesis, with a goal of translating mechanistic insights gained for new therapeutic modalities. He has published over 110 research papers in prestigious journals, including Molecular Cancer (IF=27.401), Nucleic Acids Res (IF=16.971), Journal of Hematology and Oncology (IF=17.388), Journal of Thoracic Oncology (IF=13.357), Clinical and Translational Medicine (IF=11.492), Acta Pharmaceutica Sinica B (IF=11.413). Presently, he serves as the Associate Editor for BMC Pulmonary Medicine, Frontiers in Pharmacology, and Technology in Cancer Research and Treatment.

Biochemistry Bioinformatics Cardiology Cell Biology Computational Biology Databases Epidemiology Gastroenterology & Hepatology Genomics Hematology Immunology Medical Genetics Molecular Biology Natural Products Neurology Oncology Pharmacology

Work details

Associate Professor

Xiangya Hospital, Central South University
Department of Pathology

Websites

  • PubMed Search

PeerJ Contributions

  • Articles 6
  • Edited 20
September 15, 2021
Integrative bioinformatics and experimental analysis revealed down-regulated CDC42EP3 as a novel prognostic target for ovarian cancer and its roles in immune infiltration
Yuanliang Yan, Qiuju Liang, Zhijie Xu, Qiaoli Yi
https://doi.org/10.7717/peerj.12171 PubMed 34616622
September 1, 2021
The bioinformatics and experimental analysis of AlkB family for prognosis and immune cell infiltration in hepatocellular carcinoma
Bi Peng, Yuanliang Yan, Zhijie Xu
https://doi.org/10.7717/peerj.12123 PubMed 34557360
August 3, 2021
Aberrant expression of PROS1 correlates with human papillary thyroid cancer progression
Jing Wang, Minxiang Lei, Zhijie Xu
https://doi.org/10.7717/peerj.11813 PubMed 34414029
December 10, 2019
Retrospective clinical study of renin-angiotensin system blockers in lung cancer patients with hypertension
Jie Wei, Zhiyang Zhou, Zhijie Xu, Shuangshuang Zeng, Xi Chen, Xiang Wang, Wanli Liu, Min Liu, Zhicheng Gong, Yuanliang Yan
https://doi.org/10.7717/peerj.8188 PubMed 31844581
September 3, 2019
Identification of Aloperine as an anti-apoptotic Bcl2 protein inhibitor in glioma cells
Zhijie Xu, Xiang Wang, Xi Chen, Shuangshuang Zeng, Long Qian, Jie Wei, Zhicheng Gong, Yuanliang Yan
https://doi.org/10.7717/peerj.7652 PubMed 31534865
June 17, 2019
A tropomyosin receptor kinase family protein, NTRK2 is a potential predictive biomarker for lung adenocarcinoma
Xiang Wang, Zhijie Xu, Xi Chen, Xinxin Ren, Jie Wei, Shuyi Zhou, Xue Yang, Shuangshuang Zeng, Long Qian, Geting Wu, Zhicheng Gong, Yuanliang Yan
https://doi.org/10.7717/peerj.7125 PubMed 31245181

Academic Editor on

November 28, 2023
A novel long noncoding RNA (lncRNA), LINC02657(LASTR), is a prognostic biomarker associated with immune infiltrates of lung adenocarcinoma based on unsupervised cluster analysis
Fanming Kong, Xinyu Yang, Zhichao Lu, Zongheng Liu, Yang Yang, Ziheng Wang
https://doi.org/10.7717/peerj.16167 PubMed 38047034
November 21, 2023
Head and neck squamous cell carcinoma-specific prognostic signature and drug sensitive subtypes based on programmed cell death-related genes
Chengbo Xu, Hongfang Xu, Baimei Liu
https://doi.org/10.7717/peerj.16364 PubMed 38025757
November 1, 2023
A benzochalcone derivative synchronously induces apoptosis and ferroptosis in pancreatic cancer cells
Xiaoqing Guan, Bing Zhao, Xiaodan Guan, Jinyun Dong, Jieer Ying
https://doi.org/10.7717/peerj.16291 PubMed 37927794
October 10, 2023
HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma
Yan Chen, Jianfeng Yang, Hangbin Jin, Weiwei Wen, Ying Xu, Xiaofeng Zhang, Yu Wang
https://doi.org/10.7717/peerj.16237 PubMed 37842043
August 24, 2023
A decision tree model to predict liver cirrhosis in hepatocellular carcinoma patients: a retrospective study
Zheyu Zhou, Chaobo Chen, Meiling Sun, Xiaoliang Xu, Yang Liu, Qiaoyu Liu, Jincheng Wang, Yin Yin, Beicheng Sun
https://doi.org/10.7717/peerj.15950 PubMed 37641600
June 30, 2023
Influencing factors of cardiac valve calcification (CVC) in patients with chronic kidney disease and the impact of CVC on long-term prognosis: a single-center retrospective study
Ju Wang, Jianping Xiao, Ruifeng Wang, Deguang Wang
https://doi.org/10.7717/peerj.15569 PubMed 37404480
June 22, 2023
Silencing of TRAF5 enhances necroptosis in hepatocellular carcinoma by inhibiting LTBR-mediated NF-κB signaling
Guolin Wu, Fangping Wu, Yang Qing Zhou, Wenwen Lu, Feng Lin Hu, Xiaofen Fan
https://doi.org/10.7717/peerj.15551 PubMed 37366426
June 19, 2023
C/EBPα involvement in microglial polarization via HDAC1/STAT3 pathway aggravated sevoflurane-induced cognitive impairment in aged rats
Zhao Xu, Xi Yao, Yikang Zhao, Bo Yao
https://doi.org/10.7717/peerj.15466 PubMed 37361037
June 9, 2023
Triptoquinone A and B exercise a therapeutic effect in systemic lupus erythematosus by regulating NLRC3
Qinyao Xu, Xiangzhi Zhang, Shangqing Ge, Chang Xu, Yuanfan Lv, Zongwen Shuai
https://doi.org/10.7717/peerj.15395 PubMed 37312878
May 29, 2023
CTHRC1 promotes anaplastic thyroid cancer progression by upregulating the proliferation, migration, and invasion of tumor cells
Yong Chen, Lanning Jia, Ke Zhao, Zuoyu Chen, Yue Han, Xianghui He
https://doi.org/10.7717/peerj.15458 PubMed 37273536
May 18, 2023
Hyperoside alleviates doxorubicin-induced myocardial cells apoptosis by inhibiting the apoptosis signal-regulating kinase 1/p38 pathway
Lingxia Chen, Zhi Qin, Zhong-bao Ruan
https://doi.org/10.7717/peerj.15315 PubMed 37220525
May 3, 2023
Pathological mechanism of heart failure with preserved ejection fraction in rats based on iTRAQ technology
Hang Xu, Kai Gao, Chao Liu, Tian Li, Yi Ding, Jing Ma
https://doi.org/10.7717/peerj.15280 PubMed 37159835
April 26, 2023
Advances in the diagnosis of non-occlusive mesenteric ischemia and challenges in intra-abdominal sepsis patients: a narrative review
Zhou Chen, Xiaosun Liu, Chunhui Shou, Weili Yang, Jiren Yu
https://doi.org/10.7717/peerj.15307 PubMed 37128207
April 7, 2023
T cell receptor repertoire as a novel indicator for identification and immune surveillance of patients with severe obstructive sleep apnea
Kai Li, Yue Zhuo, Yue He, Fei Lei, Pengming He, Qin Lang, Dingxiu He, Suni Zuo, Shan Chen, Xin Yang, Xueping Wen, Zhixin Zhang, Chuntao Liu
https://doi.org/10.7717/peerj.15009 PubMed 37051415
January 26, 2023
Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues
Meifu Gan, Zaixian Tai, Yijian Yu, Chao Zhang, Juan Xu
https://doi.org/10.7717/peerj.14653 PubMed 36721777
January 12, 2023
Development and validation of a novel risk model in newly diagnosed de novo bone metastatic prostate cancer (M1b): a retrospective study
Yang Zhang, Junqi Wang, Li Ding, Yuxin Zheng, Chuang Wu, Kun Wang, Wentao Xia, Peng Ge
https://doi.org/10.7717/peerj.14615 PubMed 36650836
January 4, 2023
Effect of oval foramen restriction and premature contraction of the arterial catheter on right heart function of fetuses and infants
Hongqiang Liu, Jinqiu Li, Xiaolong Cao, Yicheng Wang, Dehui Wen, Fengqun Dong, Jing Wang, Tian Li
https://doi.org/10.7717/peerj.14702 PubMed 36624751
November 28, 2022
Downregulated miRNA-491-3p accelerates colorectal cancer growth by increasing uMtCK expression
Xingkui Tang, Yukun Lin, Jialin He, Xijun Luo, Junjie Liang, Xianjun Zhu
https://doi.org/10.7717/peerj.14285 PubMed 36518289
November 28, 2022
A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors
Yaqun Li, Wenhuan Fu, Zikai Geng, Yun Song, Xionggang Yang, Tianye He, Jian Wu, Bin Wang
https://doi.org/10.7717/peerj.14432 PubMed 36518297
October 18, 2022
Clinical associations and genetic interactions of oncogenic BRAF alleles
Sebastian A. Wagner
https://doi.org/10.7717/peerj.14126 PubMed 36275468